Transcriptomic changes in invasive residual cancer after neoadjuvant chemotherapy in patients with triple-negative breast cancer

被引：0
|
作者：
Orozco, Javier [1 ]
Manughian-Peter, Ayla [1 ]
Gago, Francisco [2 ]
Chang, Grace [1 ]
Grumley, Janie [1 ]
Marzese, Diego [1 ]
机构：
[1] Providence St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA USA
[2] Italian Hosp Mendoza, Mendoza, Argentina
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581545
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [31] The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Kai Conrad Cecil Johnson
    Daniel Goldstein
    Jasmin Tharakan
    Dionisia Quiroga
    Mahmoud Kassem
    Michael Grimm
    Abdul Miah
    Craig Vargo
    Michael Berger
    Preeti Sudheendra
    Ashley Pariser
    Margaret E. Gatti-Mays
    Nicole Williams
    Daniel Stover
    Sagar Sardesai
    Robert Wesolowski
    Bhuvaneswari Ramaswamy
    Gary Tozbikian
    Patrick M. Schnell
    Mathew A. Cherian
    Oncology and Therapy, 2023, 11 : 361 - 374
  • [32] Triple-Negative Breast Cancer Who Should Receive Neoadjuvant Chemotherapy?
    Chaudhary, Lubna N.
    Wilkinson, K. Hope
    Kong, Amanda
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 27 (01) : 141 - +
  • [33] The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
    Abraham, Jean E.
    Pinilla, Karen
    Dayimu, Alimu
    Grybowicz, Louise
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Vallier, Anne-Laure
    Hardy, Richard M.
    Chan, Steve
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, Mukesh B.
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola C.
    Mcadam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    Mcmurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena M.
    NATURE, 2024, 629 (8014) : 1142 - 1148
  • [34] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Feng Ding
    Ru-Yue Chen
    Jun Hou
    Jing Guo
    Tian-Yi Dong
    World Journal of Clinical Cases, 2022, 10 (12) : 3698 - 3708
  • [35] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Ding, Feng
    Chen, Ru-Yue
    Hou, Jun
    Guo, Jing
    Dong, Tian-Yi
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3698 - 3708
  • [36] Mammographic density changes after neoadjuvant chemotherapy in triple-negative breast cancer: Association with treatment and survival outcome
    Choi, Yelim
    Kim, Soo-Yeon
    Cho, Nariya
    Moon, Woo Kyung
    CLINICAL IMAGING, 2024, 109
  • [37] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    BIOSCIENCE REPORTS, 2019, 39
  • [38] Impact of Neoadjuvant Chemotherapy on Extent of Axillary Surgery in Patients With Triple-Negative Breast Cancer
    Connor, Carol S.
    Kimler, Bruce
    Mammen, Joshua M.
    McGinness, Marilee K.
    Wagner, Jamie L.
    Alsop, Samantha M.
    Ward, Claire
    Fabian, Carol
    Khan, Qamar
    Sharma, Priyanka
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 38 - 39
  • [39] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Wu, Jiannan
    Li, Shunrong
    Jia, Weijuan
    Su, Fengxi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1505 - 1510
  • [40] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Masuda, Hiroko
    Masuda, Norikazu
    Kodama, Yoshinori
    Ogawa, Masami
    Karita, Michiko
    Yamamura, Jun
    Tsukuda, Kazunori
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    Mano, Masayuki
    Nakamori, Shoji
    Tsujinaka, Toshimasa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 911 - 917
12345